Skip to main content
. 2022 Mar 24;139(12):1785–1793. doi: 10.1182/blood.2021012328

Figure 1.

Figure 1.

Differences and consequences of current vs new consensus relapse criteria: a case study. HSCT, hematopoietic stem cell transplantation; pB-ALL, precursor B-acute lymphoblastic leukemia; TCF3-R, transcription factor 3 rearrangement.